Your full-service cell and gene biosafety partner
As a full-service cell and gene biosafety partner, GeneWerk provides clarity on the safety of the therapies in development very early on in the process.
Our GCLP-compliant services – from sample preparation to report delivery – are designed to help you to meet pre-clinical safety standards for emerging gene therapies.
Get in touchWe help you answer the questions that matter
Our comprehensive services for pre-clinical safety assessment include integration site analysis, vector persistence testing, clonal expansion, vector integration profiling, gene editing on-/off-target analysis, vector copy number (VCN), vector quality control, and immune repertoire analysis.
These services combined with our dedicated bioinformatics pipelines enable precise decision-making to successfully navigate the regulatory landscape.
Want to get in touch?
Consult with our experts about solutions to your biosafety challenges.
Latest news
Read our latest press releases and announcements below.